Stay updated with breaking news from Phasei Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN JOSE, Calif., Oct. 12, 2023 -- Rani Therapeutics Holdings, Inc. , a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it will...
This article outlines the powerful role of biomarkers in precision medicine, such as the use of autoantibodies for drug discovery against cancer.
/PRNewswire/ -- The "Phase I Market Outlook: 2022-2026" report has been added to ResearchAndMarkets.com's offering. The goal of this report is to provide...
-Treatment with VCN-01 in combination with durvalumab demonstrated an acceptable safety profile and encouraging biological activity- ROCKVILLE, Md., Sept. 05, 2022(NYSE American: SYN), a diversified
Novartis Scemblix®, with novel mechanism of action, approved by the European Commission for adult patients with chronic myeloid leukemia